Feasibility Trial Using Imaging and Biochemical Technologies to Measure Knee Cartilage Composition in Acute ACL Injury
A Multi-Center Feasibility Trial Establishing Imaging and Biochemical Technologies as Measures of Knee Cartilage Composition Following Acute ACL Injury
1 other identifier
observational
89
1 country
1
Brief Summary
This study will evaluate the bio-mechanical and biochemical abnormalities in acute ACL-injured knees over time. Data will be collected through advanced quantitative MR imaging, functional testing, and bio-specimen collection. Researchers will collect this data from the time of baseline visit, which is within 28 days of injury, through the temporal sequence of post-operative or post-injury recovery and return to activity. The hypotheses for this study are (1) that T1ρ and T2 will be significantly elevated in the lateral side of ACL-injured knees immediately after injury (indicating damage caused by initial injury), and will not fully recover at 6-month, 1-year follow ups; (2) that T1ρ and T2 will be significantly elevated in the medial side of ACL-injured knees at 1-year follow-up; and (3) that differences in the bio-marker expression patterns can be correlated with the initial MRI findings, which would provide information regarding the full spectrum of intra-articular pathology and the subsequent clinical outcomes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Nov 2013
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2013
CompletedFirst Submitted
Initial submission to the registry
December 9, 2013
CompletedFirst Posted
Study publicly available on registry
December 12, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2017
CompletedNovember 13, 2018
November 1, 2018
3.1 years
December 9, 2013
November 9, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Follow patients with acute ACL tears longitudinally using advanced, quantitative morphological MR imaging.
Patients who are within 28 days of injury will be recruited in order to capture the acute phase of injury. Quantitative morphological MRI and quantitative T1p and T2 imaging of the injured and contra-lateral knees will be captured at their baseline visit (within 7 days of initial visit), and then again at 6 months and 12 months. The aim is to investigate longitudinal changes in cartilage matrix in ACL-injured and reconstructed knees using T1ρ and T2. We hypothesize that T1ρ and T2 will be significantly higher in defined sub-compartments of injured knees compared to the contralateral un-injured knees at baseline and follow-ups. Meniscus, ligamentous and cartilage abnormalities will be graded using MRI for correlation with cartilage T1ρ and T2.
Baseline - 12 months
Secondary Outcomes (3)
Collect and store bio-specimens
Baseline - 12 months
Functional Assessments
6 months, 12 months
Patient-Reported Questionnaires
Baseline - 12 months
Study Arms (1)
Acute ACL injury
Subjects with acute ACL injury will be recruited and enrolled within 28 days of injury Serum, urine, and synovial fluid will be collected at baseline, 6wks post-injury or post-surgery, 6 months, and 1 year Patients will have a quantitative MRI on both knees 7 days after initial visit, then at 6 months and 1 year. Patients may or may not opt for ACL reconstruction Patients will have functional testing (One-legged hop tests and Star excursion balance test) at 6 months and 1 year Patients will fill out questionnaires (Knee Osteoarthritis Outcome Survey, Veteran Rand-12, Lysholm, International Knee Documentation Committee, Marx Questionnaire) at baseline, 6 weeks, 6 months, and 1 year
Eligibility Criteria
Men and Women with acute ACL injury (within 28 days)
You may qualify if:
- Skeletally mature subjects with age 13 - 70 years
- Sustain an acute full ACL rupture in one knee \< 28 day
- May or may not undergo ACL reconstruction
- Low grade injury to the collateral ligaments not resulting in instability and not requiring reconstruction will be included
You may not qualify if:
- Radiographic evidence of early osteoarthritis, defined as Grade 1 joint space narrowing or Grade 1 osteophyte formation
- Injuries to other ligaments requiring surgical intervention
- Have cartilage resurfacing procedures performed at the time of injury
- Inability to undergo the standard pre- and post-injury/operative rehabilitation
- Varus or valgus instability requiring ligament repair or reconstruction (from clinical exam at time of injury)
- History of osteoarthritis and inflammatory arthritis
- Women who are pregnant are excluded
- Previous injury and/or surgery on either knee
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of California, San Franciscolead
- Arthritis Foundationcollaborator
Study Sites (1)
UCSF Orthopaedic Institute
San Francisco, California, 94158, United States
Biospecimen
Urine, Whole Blood, Synovial Fluid
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Chunbong B Ma, MD
University of California, San Francisco
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 9, 2013
First Posted
December 12, 2013
Study Start
November 1, 2013
Primary Completion
December 1, 2016
Study Completion
December 1, 2017
Last Updated
November 13, 2018
Record last verified: 2018-11